Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion

Date:




Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Early voting begins for Rio Rancho mayoral runoff election

RIO RANCHO, N.M. (KRQE) – Tuesday, March 31 marked the start...

CRYSTAL LAKE Splits With Vocalist JOHN ROBERT CENTORRINO, Will Not Cancel Any Shows

Crystal Lake has split with vocalist John Robert Centorrino,...

Voltify Raises $30 Million to Change Way Railroads Are Powered

The Philadelphia startup aims to add battery power to...